Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzymeMyrthe J. van Dijk, Richard van Wijk, Jonathan R.A. de Wilde et al.|Blood Reviews|2023Cited by 20
Pyruvate Kinase Function Correlates With Red Blood Cell Properties and Clinical Manifestations in Sickle Cell DiseaseMarissa J.M. Traets, Minke A.E. Rab, Richard van Wijk et al.|American Journal of Hematology|2025Cited by 9
<i>Ex Vivo G</i>lucose Tracing in Red Blood Cells from Patients with Hereditary Xerocytosis Reveals Enhanced Glycolytic FluxTitine J.J. Ruiter, Judith Jans, Jonathan R.A. de Wilde et al.|Blood|2024Cited by 3
Novel Biomarkers for Assessing Clinical Severity in Hereditary Spherocytosis - Application of Routine and Advanced Diagnostic TestsJonathan R.A. de Wilde, Richard van Wijk, Maryse E. Boesveld et al.|Blood|2023Cited by 2
Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II - Results from the 8-Week Dose-Escalation PeriodThomas Doeven, Andreas Glenthøj, Eduard J. van Beers et al.|Blood|2024Cited by 2